News Related to Fibroblast Growth Factor Receptor

Related coverage linked through entity extraction aliases.

International Workshops Prioritize Drug Targets for Childhood Medulloblastoma and Rhabdoid Tumours

Jul 13, 2026

International expert workshops have identified priority therapeutic targets for medulloblastoma and rhabdoid tumours, two rare childhood cancers. For medulloblastoma, key priorities include SRC degradation, c-MYC/MYCN inhibition, and B7-H3 targeted approaches. For rhabdoid tumours, DCAF5 and MDM2 were highlighted, with EZH2 degraders showing potential.

Tempus AI Launches Preview Tool for Early Cancer Insights Within 24 Hours

May 30, 2026

Tempus has launched "Preview," an AI-powered tool that provides early cancer insights within one day of sample receipt to inform treatment planning. The tool focuses on high-impact biomarkers including MSI-H, EGFR mutations, and FGFR fusions across several cancer types. The launch aligns with expert emphasis on the critical role of early biomarker testing in personalizing therapy for EGFR-mutated NSCLC.